-The Telegraph The four Left parties today iterated the need for a debate and vote in Parliament on FDI in multi-brand retail, but suggested they might not press beyond a point if the government refused a vote, stressing that Parliament needs to function. “A decision of this nature is the right of the executive. But any major decision affecting a vast number of people must reflect the opinion of Parliament. If not,...

-The Hindu A drastic reduction in Efficacy seen in the infants during the one-year follow-up period The results of the Phase III trial of the malaria vaccine RTS,S/AS01 are greatly disappointing. The Efficacy of the vaccine in preventing clinical and severe malaria in infants aged 6 to 12 weeks is much less than what was expected. In fact, the level of protection offered is nearly half of what was reported last year...

-IANS The Supreme Court on Tuesday asked the central government to place before it the Yamuna River Action Plan with details to prevent the untreated effluents flowing into it. The apex court bench headed by Justice Swatanter Kumar also wanted to know how Rs 12,000 crore, spent by all the stakeholders for cleaning the river, was used. The court also directed that the minutes of the Yamuna River Development Authority (YRDA) be placed...

-The Hindu Business Line Pushpa M. Bhargava, former Vice-Chairman of National Knowledge Commission, has defended the recommendations of the technical committee, appointed by the Supreme Court, which called for a moratorium on the field trials of genetically modified crops. “The recommendations are in consonance with the increasing evidence and awareness in the two American continents where over 90 per cent of the world’s GM crops are grown that the increasing health problems...

-The Economic Times MUMBAI: A drug maker found overcharging will have to shell out the entire sales revenue of the medicine from the date of its launch as penalty, according to a directive issued by the country's drug price regulator. "If a company has not been booked for overcharging for selling the product without price approval, if any, pertaining to the period prior to fixation of the price of the said formulation,...